Skip to main content

Patient Care

Outpatient Nephrology Clinic

We now offer two convenient locations:

University of Kansas Medical Center Nephrology Clinic
4th floor of the Medical Office Building (MOB)
3901 Rainbow Blvd.
Mail Stop 3002
Kansas City, KS 66160

Quivira Specialty Care
12000 W 110th St.
Overland Park, KS 66210  

To schedule an appointment at either clinic, call 913.588.6074

About the outpatient clinic

Our full-service general nephrology clinic evaluates and treats patients for a broad spectrum of outpatient kidney diseases and conditions, including chronic kidney disease and its complications, glomerulonephritis, proteinuria, hematuria, hypertension, nephrolithiasis, electrolyte disorders and acid-base disturbances, and polycystic kidney disease, as well as disorders associated with systemic medical illnesses such as end-stage liver disease, lupus, and multiple myeloma. We facilitate consultation with non-renal subspecialists and other health professionals such as dieticians or social workers, and arranges for procedures such as diagnostic imaging, renal biopsies, intravenous infusions, and, when necessary, the creation of vascular or peritoneal accesses in preparation for chronic dialysis.

  • To make a referral please click here or call 913-588-5862 or toll-free 877-588-5862, Fax 913-588-5785, Email
  • To schedule an appointment, call 913.588.6074

Polycystic Kidney Disease Clinic
KUMC is a world leader in polycystic kidney disease clinical care and research.  Pioneering work by Jared Grantham, MD, the recipient of multiple national and international research awards, continues under several world-renowned scientists at KUMC.  Patients with polycystic disease are cared for in the Nephrology Clinic by Franz Winklhofer, MD, and Mireille El Ters, MD, with special expertise in this complex disorder.

Follow these links to read more about the laboratory research and clinical trials in polycystic kidney disease being conducted at the Kidney Institute.

Glomerular Disease Specialty Clinic
Dr. Ellen McCarthy specializes in the care of patients with Focal Segmental Glomerulosclerosis (FSGS), IgA nephropathy and lupus nephritis get access to expert care and cutting edge clinical trials.  To make a referral please click here or call 913-588-5862 or toll-free 877-588-5862, Fax 913-588-5785, Email To schedule an appointment, call 913.588.6074.

Outpatient Dialysis Units
Two outpatient dialysis units, staffed by KUMC nephrologists and directed by Franz Winklhofer, MD, and Ellen McCarthy, MD, treat chronic maintenance dialysis patients as well as patients anticipating recovery from dialysis-requiring acute renal failure.  Dialysis patients seen at the KUMC outpatient dialysis centers have end-stage renal disease from typical causes such as diabetes, hypertension, glomerulonephritis, polycystic kidney disease, urologic abnormalities, and other inherited and acquired disorders.  A number of patients participate in self-care therapies, such as peritoneal dialysis and home hemodialysis.In the outpatient dialysis units, complete renal care is rendered, which includes arranging for consultation with other physicians, managing vascular accesses, counseling by dieticians and social workers, and referring to the renal transplantation clinic for exploration of transplantation options. For more information on our outpatient dialysis units click here.

Inpatient Nephrology Consultation

KUMC faculty nephrologists provide care for inpatients at the University of Kansas Hospital assigned to other primary services who require specialist management by a nephrologist.  Nephrologists see inpatient consultations in the intensive care units, telemetry and progressive care ("step down") units, regular inpatient wards, maternity unit, and the Rehabilitation and Psychiatric Hospitals.  Thus, consultations originate from all services hospital-wide, including kidney transplant patients in the pre-, peri- and post-transplant periods and chronic dialysis patients who have been admitted to the hospital for a variety of renal and non-renal medical illnesses. Our nephrologists work with a multidisciplinary team that consists of trainees (medical students, internal medicine residents, and nephrology fellows), transplant surgeons, pharmacists, and case managers/social workers.

Patients seen in consultation receive care for a wide range of needs including acute or chronic dialysis (hemodialysis, peritoneal dialysis, continuous renal replacement therapy, ultrafiltration, or hemoperfusion), acute renal failure/acute kidney injury, transplantation, electrolyte disorders, hypertension, proteinuria, hematuria, congenital or acquired renal disorders, or any other nephrologic-associated abnormality.   Services provided consist of diagnostic testing for acute and chronic renal conditions; therapeutic interventions; nutritional support; patient education and counseling; and women's health services as they relate to renal issues in pregnancy. 

Kidney Transplant Program
The Center for Transplantation at The University of Kansas Hospital is the largest and most successful transplant program in the region. Patients from across the country turn to our nationally recognized program because of our reputation, expertise, reduced wait times and exceptionally high standards for comprehensive care.  KUMC has one of the shortest waiting list times in the nation (median time,18.5 months), and many patients are transplanted before they require chronic dialysis.  The program has excellent patient outcomes, with 97% one-year patient survival.  Click here to learn more about kidney transplant.

MARS 'Liver Dialysis'

MARS (Molecular Adsorbents Recirculation System), colloquially known as 'liver dialysis', is an exciting new technology that may allow for improved survival in patients with liver failure caused by drug overdose or exposure to toxins.   KUMC was one of the first centers in the U.S. to initiate the MARS following the approval of MARS by the FDA. While not a cure for liver failure, this technology, permit in conjunction with continuous renal replacement therapy, may prolong survival in critically-ill patients awaiting liver transplantation.

Read more about MARS here.

Last modified: Aug 12, 2020